{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:14:17Z","timestamp":1791947657365,"version":"4.3.4"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1054,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13311-020-00922-6","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:03:57Z","timestamp":1599735837000},"page":"1665-1680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Physiology-Based Treatment of Myoclonus"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-7887","authenticated-orcid":false,"given":"Ashley B.","family":"Pena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Caviness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00922-6_bib1","series-title":"Movement Disorders","first-page":"196","article-title":"The nosology and pathophysiology of myoclonus","author":"Marsden","year":"1983"},{"key":"10.1007\/s13311-020-00922-6_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","article-title":"Myoclonus: current concepts and recent advances","volume":"3","author":"Caviness","year":"2004","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s13311-013-0216-3","article-title":"Treatment of myoclonus","volume":"11","author":"Caviness","year":"2014","journal-title":"Neurotherapeutics."},{"key":"10.1007\/s13311-020-00922-6_bib4","doi-asserted-by":"crossref","unstructured":"Caviness JN Clinical neurophysiology of myoclonus. In: Hallett M, editor. Movement Disorders. Handbook of Clinical Neurophysiology. Amsterdam: Elsevier; 2003. pp. 521\u2013548.","DOI":"10.1016\/S1567-4231(09)70180-7"},{"issue":"8","key":"10.1007\/s13311-020-00922-6_bib5","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1212\/WNL.0000000000004996","article-title":"Electrophysiologic testing aids diagnosis and subtyping of myoclonus","volume":"90","author":"Zutt","year":"2018","journal-title":"Neurology."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1389-9457(01)00123-X","article-title":"Excessive fragmentary hypnic myoclonus: clinical and neurophysiological findings","volume":"3","author":"Vetrugno","year":"2002","journal-title":"Sleep Med."},{"issue":"4","key":"10.1007\/s13311-020-00922-6_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.22425","article-title":"Myoclonus-dystonia: an update","volume":"24","author":"Kinugawa","year":"2009","journal-title":"Mov Disord."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14802\/jmd.19064","article-title":"Principles of electrophysiological assessments for movement disorders","volume":"13","author":"Chen","year":"2020","journal-title":"J Mov Disord"},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<321::AID-MUS3>3.0.CO;2-3","article-title":"Electrophysiological studies of myoclonus","volume":"23","author":"Shibasaki","year":"2000","journal-title":"Muscle Nerve."},{"key":"10.1007\/s13311-020-00922-6_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","article-title":"Autoimmune and paraneoplastic movement disorders: an update","volume":"385","author":"Baizabal-Carvallo","year":"2018","journal-title":"J Neurol Sci."},{"issue":"7","key":"10.1007\/s13311-020-00922-6_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0025-6196(11)63006-1","article-title":"Myoclonus","volume":"71","author":"Caviness","year":"1996","journal-title":"Mayo Clin Proc."},{"key":"10.1007\/s13311-020-00922-6_bib12","doi-asserted-by":"crossref","unstructured":"Obeso JA, Rothwell JC, Marsden CD. The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy. Brain. 1985;108 (Pt 1). https:\/\/doi.org\/10.1093\/brain\/108.1.193","DOI":"10.1093\/brain\/108.1.193"},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00922-6_bib13","first-page":"S67","article-title":"Myoclonus: relation to epilepsy","volume":"26","author":"Hallett","year":"1985","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-020-00922-6_bib14","unstructured":"Neuroscan [computer software]. Version 4.3. El Paso, TX: Compumedics, 2003."},{"issue":"5","key":"10.1007\/s13311-020-00922-6_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archneur.1977.00500170020003","article-title":"Epilepsia partialis continua. A review of 32 cases","volume":"34","author":"Thomas","year":"1977","journal-title":"Arch Neurol."},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1157.1986.tb03525.x","article-title":"Valproate reduces excitability by blockage of sodium and potassium conductance","volume":"27","author":"VanDongen","year":"1986","journal-title":"Epilepsia."},{"issue":"Pt 3","key":"10.1007\/s13311-020-00922-6_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/112.3.765","article-title":"The treatment of severe action myoclonus","volume":"112","author":"Obeso","year":"1989","journal-title":"Brain."},{"key":"10.1007\/s13311-020-00922-6_bib18","first-page":"49","article-title":"Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen","volume":"26","author":"Fahn","year":"1979","journal-title":"Adv Neurol."},{"key":"10.1007\/s13311-020-00922-6_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2377-6-11","article-title":"Dose-dependent improvement of myoclonic hyperkinesia due to valproic acid in eight Huntington's disease patients: a case series","volume":"6","author":"Saft","year":"2006","journal-title":"BMC Neurol"},{"issue":"37","key":"10.1007\/s13311-020-00922-6_bib20","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.2174\/1381612823666170809114654","article-title":"Update on pharmacological treatment of progressive myoclonus epilepsies","volume":"23","author":"Ferlazzo","year":"2017","journal-title":"Curr Pharm Des."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/mds.870080112","article-title":"Effectiveness of piracetam in cortical myoclonus","volume":"8","author":"Brown","year":"1993","journal-title":"Mov Disord."},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/jnnp.64.3.344","article-title":"Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo","volume":"64","author":"Koskiniemi","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"6","key":"10.1007\/s13311-020-00922-6_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mds.870110615","article-title":"Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus\/Piracetam Study Group","volume":"11","author":"Ikeda","year":"1996","journal-title":"Mov Disord."},{"issue":"S2","key":"10.1007\/s13311-020-00922-6_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1684\/epd.2016.0861","article-title":"Myoclonus and seizures in progressive myoclonus epilepsies: pharmacology and therapeutic trials","volume":"18","author":"Michelucci","year":"2016","journal-title":"Epileptic Disord."},{"issue":"12","key":"10.1007\/s13311-020-00922-6_bib25","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.20530","article-title":"Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study","volume":"20","author":"Striano","year":"2005","journal-title":"Mov Disord."},{"issue":"6","key":"10.1007\/s13311-020-00922-6_bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0013-9580.2004.56902.x","article-title":"Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations","volume":"45","author":"Magaudda","year":"2004","journal-title":"Epilepsia."},{"issue":"20","key":"10.1007\/s13311-020-00922-6_bib27","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.4103\/0366-6999.243568","article-title":"Antimyoclonic effect of levetiracetam and clonazepam combined treatment on myoclonic epilepsy with ragged-red fiber syndrome with m.8344A>G mutation","volume":"131","author":"Su","year":"2018","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14802\/jmd.14007","article-title":"Suppression of myoclonus in corticobasal de-generation by levetiracetam","volume":"7","author":"Cho","year":"2014","journal-title":"J Mov Disord."},{"issue":"12","key":"10.1007\/s13311-020-00922-6_bib29","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00702-009-0301-2","article-title":"Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases","volume":"116","author":"Kov\u00e1cs","year":"2009","journal-title":"J Neural Transm (Vienna)."},{"issue":"10","key":"10.1007\/s13311-020-00922-6_bib30","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/mds.25433","article-title":"Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15","volume":"28","author":"Orsucci","year":"2013","journal-title":"Mov Disord."},{"issue":"12","key":"10.1007\/s13311-020-00922-6_bib31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00702-007-0788-3","article-title":"Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus","volume":"114","author":"Tai","year":"2007","journal-title":"J Neural Transm (Vienna)."},{"issue":"2","key":"10.1007\/s13311-020-00922-6_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/epi.13275","article-title":"Brivaracetam in Unverricht-Lundborg disease (EPM1): results from two randomized, double-blind, placebo-controlled studies","volume":"57","author":"K\u00e4lvi\u00e4inen","year":"2016","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-020-00922-6_bib33","first-page":"629","article-title":"Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT","volume":"43","author":"Jenner","year":"1986","journal-title":"Adv Neurol."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1212\/WNL.26.1.24","article-title":"Intention myoclonus: successful treatment with clonazepam","volume":"26","author":"Goldberb","year":"1976","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00922-6_bib35","first-page":"157","article-title":"Posthypoxic action myoclonus: literature review update","volume":"43","author":"Fahn","year":"1986","journal-title":"Adv Neurol."},{"issue":"10","key":"10.1007\/s13311-020-00922-6_bib36","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.clinph.2019.07.006","article-title":"Low-dose perampanel improves refractory cortical myoclonus by the dispersed and suppressed paroxysmal depolarization shifts in the sensorimotor cortex","volume":"130","author":"Oi","year":"2019","journal-title":"Clin Neurophysiol."},{"key":"10.1007\/s13311-020-00922-6_bib37","doi-asserted-by":"crossref","first-page":"100215","DOI":"10.1016\/j.ensci.2019.100215","article-title":"Perampanel improved intractable myoclonus in two patients with myoclonus epilepsy","volume":"17","author":"Iijima","year":"2019","journal-title":"eNeurologicalSci"},{"key":"10.1007\/s13311-020-00922-6_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebcr.2015.06.007","article-title":"Use of perampanel in one case of super-refractory hypoxic myoclonic status: case report","volume":"4","author":"Santamarina","year":"2015","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1007\/s13311-020-00922-6_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ebcr.2016.05.001","article-title":"Add-on perampanel in Lance-Adams syndrome","volume":"6","author":"Steinhoff","year":"2016","journal-title":"Epilepsy Behav Case Rep"},{"issue":"2","key":"10.1007\/s13311-020-00922-6_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1212\/CPJ.0000000000000440","article-title":"Postsurgical cortical myoclonus responsive to perampanel","volume":"8","author":"Bianchini","year":"2018","journal-title":"Neurol Clin Pract."},{"key":"10.1007\/s13311-020-00922-6_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/WNF.0b013e3182613e06","article-title":"Relief of intractable posthypoxic myoclonus after administration of agomelatine","volume":"35","author":"de la Gonz\u00e1lez Aleja","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"10.1007\/s13311-020-00922-6_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/WNF.0b013e3181e1613f","article-title":"Posthypoxic myoclonus (Lance-Adams syndrome) treated with lacosamide","volume":"33","author":"Galldiks","year":"2010","journal-title":"Clin Neuropharmacol."},{"key":"10.1007\/s13311-020-00922-6_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5334\/tohm.323","article-title":"Post-hypoxic myoclonus: current concepts, neurophysiology, and treatment","volume":"6","author":"Gupta","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"2","key":"10.1007\/s13311-020-00922-6_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(97)00069-7","article-title":"Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients","volume":"29","author":"Kyllerman","year":"1998","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0920-1211(01)00282-0","article-title":"Long-term observations of two siblings with Lafora disease treated with zonisamide","volume":"46","author":"Yoshimura","year":"2001","journal-title":"Epilepsy Res."},{"issue":"12","key":"10.1007\/s13311-020-00922-6_bib46","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.wnl.0000188670.38576.bd","article-title":"A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor","volume":"65","author":"Frucht","year":"2005","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00922-6_bib47","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00415-015-7748-x","article-title":"Alleviation of myoclonus after bilateral pallidal deep brain stimulation for Lance-Adams syndrome","volume":"262","author":"Asahi","year":"2015","journal-title":"J Neurol."},{"key":"10.1007\/s13311-020-00922-6_bib48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5334\/tohm.342","article-title":"Improvement of post-hypoxic myoclonus with bilateral pallidal deep brain stimulation: a case report and review of the literature","volume":"7","author":"Ramdhani","year":"2017","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"4","key":"10.1007\/s13311-020-00922-6_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000315464","article-title":"Thalamic deep brain stimulation for the treatment of action myoclonus caused by perinatal anoxia","volume":"88","author":"Kobayashi","year":"2010","journal-title":"Stereotact Funct Neurosurg."},{"issue":"2","key":"10.1007\/s13311-020-00922-6_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mdc3.12372","article-title":"Deep brain stimulation in three related cases of North Sea progressive myoclonic epilepsy from South Africa","volume":"4","author":"Anderson","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1167.2010.02884.x","article-title":"Chronic high-frequency deep-brain stimulation in progressive myoclonic epilepsy in adulthood\u2013report of five cases","volume":"52","author":"Wille","year":"2011","journal-title":"Epilepsia."},{"issue":"10","key":"10.1007\/s13311-020-00922-6_bib52","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1528-1167.2007.01166.x","article-title":"Chronic high-frequency deep brain stimulation of the STN\/SNr for progressive myoclonic epilepsy","volume":"48","author":"Vesper","year":"2007","journal-title":"Epilepsia."},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1684\/epd.2019.1072","article-title":"Selective deep brain stimulation in the substantia nigra reduces myoclonus in progressive myoclonic epilepsy: a novel observation and short review of the literature","volume":"21","author":"di Giacopo","year":"2019","journal-title":"Epileptic Disord."},{"key":"10.1007\/s13311-020-00922-6_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.brainresbull.2018.05.016","article-title":"Transcranial magnetic stimulation in myoclonus of different aetiologies","volume":"140","author":"Nardone","year":"2018","journal-title":"Brain Res Bull."},{"key":"10.1007\/s13311-020-00922-6_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yebeh.2017.11.031","article-title":"Effect of repetitive transcranial magnetic stimulation on action myoclonus: a pilot study in patients with EPM1","volume":"80","author":"Rossi Sebastiano","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.yebeh.2008.09.007","article-title":"Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua","volume":"14","author":"Rotenberg","year":"2009","journal-title":"Epilepsy Behav."},{"issue":"1-2","key":"10.1007\/s13311-020-00922-6_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2005.03.035","article-title":"Low-frequency transcranial magnetic stimulation for epilepsia partialis continua due to cortical dysplasia","volume":"234","author":"Misawa","year":"2005","journal-title":"J Neurol Sci."},{"issue":"7","key":"10.1007\/s13311-020-00922-6_bib58","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.clinph.2007.04.014","article-title":"Low frequency repetitive transcranial magnetic stimulation over premotor cortex can improve cortical tremor","volume":"118","author":"Houdayer","year":"2007","journal-title":"Clin Neurophysiol."},{"key":"10.1007\/s13311-020-00922-6_bib59","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ana.410370204","article-title":"Basic mechanisms of generalized absence seizures","volume":"37","author":"Snead","year":"1995","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-020-00922-6_bib60","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1212\/01.wnl.0000336969.98241.17","article-title":"Nerve fiber impairment of anterior thalamocortical circuitry in juvenile myoclonic epilepsy","volume":"71","author":"Deppe","year":"2008","journal-title":"Neurology."},{"issue":"2","key":"10.1007\/s13311-020-00922-6_bib61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-1211(97)00080-6","article-title":"Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide","volume":"29","author":"Wallace","year":"1998","journal-title":"Epilepsy Res."},{"issue":"10","key":"10.1007\/s13311-020-00922-6_bib62","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.seizure.2013.07.006","article-title":"Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial","volume":"22","author":"Machado","year":"2013","journal-title":"Seizure."},{"issue":"10","key":"10.1007\/s13311-020-00922-6_bib63","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1212\/WNL.56.10.1424-a","article-title":"Exacerbation of juvenile myoclonic epilepsy with lamotrigine","volume":"56","author":"Carrazana","year":"2001","journal-title":"Neurology."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eplepsyres.2006.05.013","article-title":"Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy","volume":"71","author":"Specchio","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1007\/s13311-020-00922-6_bib65","doi-asserted-by":"crossref","unstructured":"Manganotti P, Tamburin S, Bongiovanni LG, Zanette G, Fiaschi A. Motor responses to afferent stimulation in juvenile myoclonic epilepsy. Epilepsia 2004;45:77\u201380.","DOI":"10.1111\/j.0013-9580.2004.21003.x"},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/epi.12028","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia."},{"issue":"5","key":"10.1007\/s13311-020-00922-6_bib67","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/WNL.54.5.1201","article-title":"Intravenous valproic acid for myoclonic status epilepticus","volume":"54","author":"Sheth","year":"2000","journal-title":"Neurology."},{"issue":"10","key":"10.1007\/s13311-020-00922-6_bib68","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/epi.12352","article-title":"Deep brain stimulation of the centromedian thalamic nucleus for the treatment of generalized and frontal epilepsies","volume":"54","author":"Valent\u00edn","year":"2013","journal-title":"Epilepsia."},{"issue":"14","key":"10.1007\/s13311-020-00922-6_bib69","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/mds.22273","article-title":"Electrophysiological features of myoclonus-dystonia","volume":"23","author":"Li","year":"2008","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-020-00922-6_bib70","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1212\/WNL.0000000000002631","article-title":"A randomized, controlled, double-blind crossover trial of zonisamide in myoclonus-dystonia","volume":"86","author":"Hanique","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1007\/s13311-020-00922-6_bib71","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1212\/WNL.54.8.1706","article-title":"Gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia","volume":"54","author":"Priori","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.1007\/s13311-020-00922-6_bib72","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.parkreldis.2014.09.029","article-title":"Treatment of myoclonus-dystonia syndrome with tetrabenazine","volume":"20","author":"Luciano","year":"2014","journal-title":"Parkinsonism Relat Disord."},{"issue":"6","key":"10.1007\/s13311-020-00922-6_bib73","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.26215","article-title":"Pallidal stimulation for myoclonus-dystonia: ten years' outcome in two patients","volume":"30","author":"Roze","year":"2015","journal-title":"Mov Disord."},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib74","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clineuro.2008.10.015","article-title":"Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome","volume":"111","author":"Kuncel","year":"2009","journal-title":"Clin Neurol Neurosurg."},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib75","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.25326","article-title":"Surgical treatment of myoclonus dystonia syndrome","volume":"28","author":"Rughani","year":"2013","journal-title":"Mov Disord."},{"issue":"11","key":"10.1007\/s13311-020-00922-6_bib76","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/mds.23312","article-title":"Pallidal and thalamic deep brain stimulation in myoclonus-dystonia","volume":"25","author":"Gruber","year":"2010","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-020-00922-6_bib77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archneurol.2011.717","article-title":"Topiramate effect in opsoclonus-myoclonus-ataxia syndrome","volume":"69","author":"Fernandes","year":"2012","journal-title":"Arch Neurol"},{"issue":"Pt 2","key":"10.1007\/s13311-020-00922-6_bib78","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib79","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11910-014-0512-2","article-title":"An update and review of the treatment of myoclonus","volume":"15","author":"Mills","year":"2015","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.42.1.52","article-title":"Uraemic myoclonus: an example of reticular reflex myoclonus?","volume":"42","author":"Chadwick","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"15","key":"10.1007\/s13311-020-00922-6_bib81","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/WNL.0b013e3181a0fd50","article-title":"Propriospinal myoclonus revisited: clinical, neurophysiologic, and neuroradiologic findings","volume":"72","author":"Roze","year":"2009","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00922-6_bib82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smrv.2014.10.007","article-title":"Propriospinal myoclonus: the spectrum of clinical and neurophysiological phenotypes","volume":"22","author":"Antelmi","year":"2015","journal-title":"Sleep Med. Rev."},{"key":"10.1007\/s13311-020-00922-6_bib83","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.20927","article-title":"Electromyography patterns of propriospinal myoclonus can be mimicked voluntarily","volume":"21","author":"Kang","year":"2006","journal-title":"Mov Disord"},{"issue":"8","key":"10.1007\/s13311-020-00922-6_bib84","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00415-010-5531-6","article-title":"Axial jerks: a clinical spectrum ranging from propriospinal to psychogenic myoclonus","volume":"257","author":"van der Salm","year":"2010","journal-title":"J Neurol."},{"issue":"16","key":"10.1007\/s13311-020-00922-6_bib85","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/mds.22812","article-title":"Idiopathic spinal myoclonus: a clinical and neurophysiological assessment of a movement disorder of uncertain origin","volume":"24","author":"Esposito","year":"2009","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-020-00922-6_bib86","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archneur.1986.00520100039012","article-title":"Segmental myoclonus. Clinical and pharmacologic study","volume":"43","author":"Jankovic","year":"1986","journal-title":"Arch Neurol."},{"key":"10.1007\/s13311-020-00922-6_bib87","doi-asserted-by":"crossref","unstructured":"Termsarasab P, Thammongkolchai T, Frucht SJ. Spinal-generated movement disorders: a clinical review [published correction appears in J Clin Mov Disord. 2016 22;3:18]. J Clin Mov Disord. 2015;2:18. Published 2015 Dec 24. https:\/\/doi.org\/10.1186\/s40734-015-0028-1","DOI":"10.1186\/s40734-015-0028-1"},{"key":"10.1007\/s13311-020-00922-6_bib88","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mds.870110628","article-title":"Treatment of palatal myoclonus with sumatriptan","volume":"11","author":"Scott","year":"1996","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-020-00922-6_bib89","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/seiz.2002.0592","article-title":"Palatal myoclonus responding to lamotrigine","volume":"11","author":"Nasr","year":"2002","journal-title":"Seizure."},{"issue":"4","key":"10.1007\/s13311-020-00922-6_bib90","first-page":"253","article-title":"Therapy of myoclonus","volume":"3","author":"Obeso","year":"1995","journal-title":"Clin Neurosci."},{"issue":"5","key":"10.1007\/s13311-020-00922-6_bib91","first-page":"672","article-title":"Treatment of essential palatal myoclonus in a 10-year-old girl with botulinum neurotoxin","volume":"27","author":"Krause","year":"2006","journal-title":"Otol Neurotol."},{"key":"10.1007\/s13311-020-00922-6_bib92","first-page":"392","article-title":"Botulinum toxin injection for objective tinnitus from palatal myoclonus: a case report","volume":"85","author":"Srirompotong","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1007\/s13311-020-00922-6_bib93","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00415-006-0039-9","article-title":"Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature","volume":"253","author":"Penney","year":"2006","journal-title":"J Neurol."},{"issue":"5","key":"10.1007\/s13311-020-00922-6_bib94","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/lary.23485","article-title":"Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics","volume":"124","author":"Sinclair","year":"2014","journal-title":"Laryngoscope."},{"issue":"5","key":"10.1007\/s13311-020-00922-6_bib95","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00129492-200309000-00003","article-title":"Treatment for severe palatoclonus by occlusion of the Eustachian tube","volume":"24","author":"Ensink","year":"2003","journal-title":"Otol Neurotol."},{"key":"10.1007\/s13311-020-00922-6_bib96","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/mds.21928","article-title":"Drug-induced and psychogenic resting suprahyoid neck and tongue tremors","volume":"23","author":"Baik","year":"2008","journal-title":"Movement Disord"},{"key":"10.1007\/s13311-020-00922-6_bib97","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.10632","article-title":"Psychogenic palatal tremor","volume":"19","author":"Williams","year":"2004","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-020-00922-6_bib98","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0404.1990.tb00974.x","article-title":"Idiopathic palatal myoclonus","volume":"81","author":"Yokota","year":"1990","journal-title":"Acta Neurol Scand."},{"issue":"4","key":"10.1007\/s13311-020-00922-6_bib99","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jnnp.73.4.457","article-title":"Amelioration of spinal myoclonus with levetiracetam","volume":"73","author":"Keswani","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1007\/s13311-020-00922-6_bib100","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1212\/01.wnl.0000246115.54997.1b","article-title":"Spinal myoclonus following herpes zoster radiculitis","volume":"68","author":"Estraneo","year":"2007","journal-title":"Neurology."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib101","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1590\/S0004-282X2003000100022","article-title":"A case of primary spinal myoclonus: clinical presentation and possible mechanisms involved","volume":"61","author":"Campos","year":"2003","journal-title":"Arq Neuropsiquiatr."},{"issue":"2","key":"10.1007\/s13311-020-00922-6_bib102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/mds.870090221","article-title":"Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin","volume":"9","author":"Polo","year":"1994","journal-title":"Mov Disord."},{"issue":"1","key":"10.1007\/s13311-020-00922-6_bib103","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/1531-8257(199901)14:1<182::AID-MDS1040>3.0.CO;2-8","article-title":"Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A","volume":"14","author":"Lagueny","year":"1999","journal-title":"Mov Disord."},{"issue":"9","key":"10.1007\/s13311-020-00922-6_bib104","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/mus.880150909","article-title":"Treatment of hemifacial spasm with botulinum toxin","volume":"15","author":"Yoshimura","year":"1992","journal-title":"Muscle Nerve."},{"issue":"3","key":"10.1007\/s13311-020-00922-6_bib105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1212\/WNL.32.3.286","article-title":"Carbamazepine for hemifacial spasm","volume":"32","author":"Alexander","year":"1982","journal-title":"Neurology."},{"issue":"2","key":"10.1007\/s13311-020-00922-6_bib106","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-0404.2001.104002110.x","article-title":"Gabapentin in the treatment of hemifacial spasm","volume":"104","author":"Daniele","year":"2001","journal-title":"Acta Neurol Scand."},{"issue":"12","key":"10.1007\/s13311-020-00922-6_bib107","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/jnnp.44.12.1100","article-title":"Hemifacial spasm: a long term follow-up of patients treated by posterior fossa surgery and facial nerve wrapping","volume":"44","author":"Kaye","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1007\/s13311-020-00922-6_bib108","series-title":"Current Controversies in Neurosurgery","article-title":"Vascular compression of the facial nerve at the brainstem in hemifacial spasm: treatment by microsurgical decompression","author":"Janetta","year":"1976"},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00922-6_bib109","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.parkreldis.2015.09.016","article-title":"Electrophysiological evaluation of psychogenic movement disorders","volume":"22","author":"Kamble","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1007\/s13311-020-00922-6_bib110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.03.029","article-title":"Improving neurophysiological biomarkers for functional myoclonic movements","volume":"51","author":"Beudel","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"issue":"4","key":"10.1007\/s13311-020-00922-6_bib111","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/WCO.0b013e3283551bc1","article-title":"Functional (psychogenic) movement disorders","volume":"25","author":"Czarnecki","year":"2012","journal-title":"Curr Opin Neurol."},{"key":"10.1007\/s13311-020-00922-6_bib112","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/B978-0-12-801772-2.00021-7","article-title":"Functional jerks, tics, and paroxysmal movement disorders","volume":"139","author":"Dreissen","year":"2016","journal-title":"Handb Clin Neurol."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00922-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:05:05Z","timestamp":1761807905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1878747923012655"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00922-6","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiology-Based Treatment of Myoclonus","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00922-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}